Spyre Therapeutics (SYRE) Shares Outstanding (2014 - 2026)
Spyre Therapeutics (SYRE) recorded Weighted Average Shares Outstanding of 88.41 million in Q3 2026, up 45.5% from 60.78 million a year earlier and up 4.3% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Shares Outstanding (2014 - 2026) Analysis & Trends
For FY2025, Spyre Therapeutics reported Weighted Average Shares Outstanding of 64.42 million, up 35.7% from FY2024.
- Annual Weighted Average Shares Outstanding has a five-year compound annual growth rate of 3.8% (FY2020 to FY2025).
- Across earlier years, Weighted Average Shares Outstanding came in at 47.49 million in FY2024 (+546.9%), 7.34 million in FY2023 (-91.3%), 84.28 million in FY2022 (+28.2%) and 65.74 million in FY2021 (+23.2%).
- The Q3 2026 figure is the highest quarterly Weighted Average Shares Outstanding since Q2 2023.
- On a year-over-year basis, Weighted Average Shares Outstanding has increased for eight consecutive quarters, with growth averaging 101.4% over the last eight quarters.
- Peak year-over-year performance for Weighted Average Shares Outstanding in the last five years was growth of 546.9% in Q4 2024, against a decline of 95.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 84.73 million (Q2 2026), 78.55 million (Q1 2026) and 64.42 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - | 88.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88.41 Mn |
| Jun 30, 2026 | 84.73 Mn |
| Mar 31, 2026 | 78.55 Mn |
| Dec 31, 2025 | 64.42 Mn |
| Sep 30, 2025 | 60.78 Mn |
| Jun 30, 2025 | 60.70 Mn |
| Mar 31, 2025 | 60.63 Mn |
| Dec 31, 2024 | 47.49 Mn |
| Sep 30, 2024 | 51.25 Mn |
| Jun 30, 2024 | 45.83 Mn |
| Mar 31, 2024 | 37.12 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Sep 30, 2023 | 4.29 Mn |
| Jun 30, 2023 | 3.82 Mn |
| Mar 31, 2023 | 3.77 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 3.77 Mn |
| Jun 30, 2022 | 3.29 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 2.63 Mn |
API Access
Spyre Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();